Zafirlukast
- Level
- Commodity
- Parent
- 51161500
- Below
- 0
- Links · KBLI
- 9
Definition
UNSPSC 51161563This classification denotes an anti-asthmatic agent with the molecular formula C31H33N3O6S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier XZ629S5L50, chemically known as ici 204,219 but generally known as zafirlukast, which bears US NIH Compound Identifier 5717. European Medicines Agency schedules Zafirlukast in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00128MIG. The term ZAFIRLUKAST is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 9, No. 3, 1995, List 35). World Health Organization schedules zafirlukast in its Anatomical Therapeutic Chemical (ATC) Classification. ZAFIRLUKAST is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule zafirlukast under HS 29350090 and SITC 51580. As of Q4 2014, ZAFIRLUKAST remains the US FDA Preferred Term for this commodity. Zafirlukast bears US NLM identifiers UMLS ID C0378466 and NCI Concept Code C47785. SMILES: S(=O)(=O)(NC(=O)C1CC(OC)C(CC2C3C(N(C2)C)CCC(NC(=O)OC2CCCC2)C3)CC1)C1C(CCCC1)C.
Same parent
Under 51161500 · 56Activities that produce or sell this
KBLI · 9Inherited from family 51160000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.